You want to get back to your favorite activities and people – and that starts with feeling confident in your COVID-19 status.
Make the best decisions for yourself and those around you with the help of our BIOCARD® Pro COVID-19 Rapid Antigen Test, which ensures fast, highly accurate detection, including the Omicron variant.
New Day’s BIOCARD COVID-19 accurately detects Omicron and Delta variants. Get fast, accurate results in just 10 minutes so you can protect yourself and your loved ones.
When you are responsible for the healthcare of others, you need a COVID-19 test that is highly accurate and makes testing easy and cost effective. Millions trust New Day’s BIOCARD Covid-19 test as it detects Omicron and Delta variants.
Identified negative cases 100% of the time compared to the standard of care RT-PCR test (NPA).1
Breadth of Detection
Our test can detect previous and newer variants of COVID-19, such as Delta, Omicron and Deltacron,– so you can identify a positive COVID status sooner and be confident in negative results that allow you to return to normal life.
Picked up positive cases in 86.7% of symptomatic patients within the first 9 days of symptom onset compared to the standard of care RT-PCR test (PPA).1
With BIOCARD® Pro Rapid Antigen Test,
trusted results are just a test away.
How To Use the Test
Instructions For Use (IFU): Please carefully read and follow all instructions. It is important that you complete the test steps as accurately as possible to ensure reliable results.
For additional information about our test, view our frequently asked questions.
Frequently Ask Questions
Still have questions,
call customer service toll-free: 877-639-3293
- This product has been authorized by the FDA under an Emergency Use Authoization (EUA)
- This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.
- The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
CE Mark for Professional use.
This item is currently not available for sale in the USA until FDA authorized. This page is made available for informational purposes only.
1 In symptomatic patients.